Keros Therapeutics, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↓-45.1% -$278M
$338M
Current Assets↓-46.4% -$273M
$315M
Cash & Equivalents↓-48.7% -$273M
$287M
Receivables↑+30.1% +$825K
$4M
Net PPE↑+1.4% +$60K
$4M
Total Liabilities↓-21.3% -$9M
$35M
Current Liabilities↓-25.6% -$7M
$20M
Account Payables↓-57.3% -$3M
$2M
Stockholders Equity↓-47.0% -$268M
$303M
Retained Earnings↑+15.3% +$87M
$-482M
Operating Lease ROU Asset↓-12.5% -$2M
$17M
Operating Lease Liability↑+0.0% +$0
$17M
Gross PP&E↑+21.5% +$2M
$9M
Accumulated Depreciation↑+50.4% +$1M
$4M
Contract Liability
$155K
Contract Liability (Current)
$155K